World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
59
Citations
12701
World Ranking
2020
National Ranking
1005

Ryszard Kole publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Ryszard Kole sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 121 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Ryszard Kole D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Ryszard Kole sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 59 D-Index — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Ryszard Kole is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research encompasses a range of fields primarily within biochemistry, genetics, molecular biology, and medicine. The scientist has contributed to multiple subfields including molecular biology, pulmonary and respiratory medicine, genetics, infectious diseases, and surgery.

Their scholarly output includes publications in various peer-reviewed journals and institutional repositories. Frequent publication venues include:

  • UNC Libraries
  • Nature Medicine
  • Nucleic Acids Research
  • Human Gene Therapy
  • The Journal of Infectious Diseases

Ryszard Kole's research topics mainly focus on RNA interference and gene delivery, RNA research and splicing, RNA modifications and cancer, DNA and nucleic acid chemistry, RNA and protein synthesis mechanisms, parvovirus B19 infection studies, and nuclear structure and function. These areas reflect a broad interest in nucleic acid biology and therapeutic applications.

Among their recent published papers are:

  • "A targeted antisense therapeutic approach for Hutchinson-Gilford progeria syndrome," 2021, Nature Medicine
  • "Enhanced delivery of peptide-morpholino oligonucleotides with a small molecule to correct splicing defects in the lung," 2021, Nucleic Acids Research
  • "Engineered U7 Small Nuclear RNA Restores Correct β-Globin Pre-mRNA Splicing in Mouse β IVS2-654 -Thalassemic Erythroid Progenitor Cells," 2020, Human Gene Therapy
  • "The Importance of Bcl-x L in the Survival of Human RPE Cells," 2021, UNC Libraries
  • "Post-Pandemic Dynamics of the Global Circulation of Human Metapneumovirus and Respiratory Syncytial Virus," 2025, The Journal of Infectious Diseases

Ryszard Kole collaborates frequently with other researchers, including:

  • Peter Sazani
  • Hong M. Moulton
  • Natee Jearawiriyapaisarn
  • Jennifer Roberts
  • Yan L. Dang

Their work spans fundamental and applied research in molecular mechanisms underlying disease as well as therapeutic development, particularly focusing on RNA-targeted strategies.

Best Publications

  • RNA therapeutics: beyond RNA interference and antisense oligonucleotides

    Ryszard Kole;Adrian R. Krainer;Sidney Altman

  • Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.

    Zbigniew Dominski;Ryszard Kole

  • Up-Regulation of Luciferase Gene Expression with Antisense Oligonucleotides: Implications and Applications in Functional Assay Development†

    Shin-Hong Kang;Moo-Jung Cho;Ryszard Kole

  • Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleotides

    Halina Sierakowska;Maria J. Sambade;Sudhir Agrawal;Ryszard Kole

  • Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice.

    Natee Jearawiriyapaisarn;Hong M Moulton;Brian Buckley;Jennifer Roberts

  • Systemically delivered antisense oligomers upregulate gene expression in mouse tissues

    Peter Sazani;Federica Gemignani;Shin-Hong Kang;Martin A. Maier

  • Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides

    Stephen D Wilton;Frances Lloyd;Kylie Carville;Sue Fletcher

  • Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing

    Peter Sazani;Ryszard Kole

  • Selection of splice sites in pre-mRNAs with short internal exons.

    Zbigniew Dominski;Ryszard Kole

  • Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs

    Peter Sazani;Shin-Hong Kang;Martin A. Maier;Changfu Wei

  • RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds

    Paul J. Furdon;Zbigniew Dominski;Ryszard Kole

  • Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients.

    Giuseppina Lacerra;Halina Sierakowska;Clementina Carestia;Suthat Fucharoen

  • Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents

    Danielle R. Mercatante;James L. Mohler;Ryszard Kole

  • Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides.

    Kenneth J. Friedman;Jolanta Kole;Jonathan A. Cohn;Jonathan A. Cohn;Michael R. Knowles

  • Modification of Alternative Splicing of Bcl-x Pre-mRNA in Prostate and Breast Cancer Cells ANALYSIS OF APOPTOSIS AND CELL DEATH

    Danielle R. Mercatante;Carl D. Bortner;John A. Cidlowski;Ryszard Kole

  • Therapeutic potential of splice-switching oligonucleotides.

    John Bauman;Natee Jearawiriyapaisarn;Ryszard Kole

  • Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs.

    Linda Gorman;Daniel Suter;Victoria Emerick;Daniel Schümperli

  • Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.

    Rudolph L Juliano;S. Alahari;H. Yoo;R. Kole

  • Antisense oligonucleotide inhibiting aberrant splicing and method of using the same

    Ryszard Kole;コール,リスザード;Zbigniew Dominski;ドミンスキー,ズビグニエフ

  • E. coli RNAase P has a required RNA component in vivo

    Ryszard Kole;Madeline F. Baer;Benjamin C. Stark;Sidney Altman

Frequent Co-Authors

Suthat Fucharoen
Suthat Fucharoen Mahidol University
Daniel Schümperli
Daniel Schümperli University of Bern
Sue Fletcher
Sue Fletcher Murdoch University
Steve D. Wilton
Steve D. Wilton University of Western Australia
Sudhir Agrawal
Sudhir Agrawal University of Massachusetts Chan Medical School
Muthiah Manoharan
Muthiah Manoharan Alnylam Pharmaceuticals (United States)
Martin Maier
Martin Maier Alnylam Pharmaceuticals (United States)
Patrick L. Iversen
Patrick L. Iversen Oregon State University
Jonathan A. Cohn
Jonathan A. Cohn Duke University
Nobuyo Maeda
Nobuyo Maeda University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees closely related to Molecular Biology can uncover valuable career pathways—especially for students considering flexible options or career changes. For example, if you are interested in library research or scientific information management, pursuing one of the cheapest masters in library science may open doors to roles in academic, hospital, or research libraries.

Those fascinated by human communication and healthcare may consider speech and language careers. If you already hold a bachelor’s degree, you can look into asha approved slp programs for advanced credentials. Alternatively, speech pathology bridge programs online allow non-SLP majors to transition into this in-demand field.

For those interested in healthcare but without prior nursing experience, accelerated bsn programs for non nurses provide a fast-track path into nursing careers. Online and hybrid programs offer the flexibility to upskill while balancing other commitments. These varied educational options can help you tailor your career journey based on your interests and professional goals.

Best Scientists Citing Ryszard Kole

Trending Scientists

Recently Published Articles